Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
Company (NYSE:DBVT) reports the total number of shares and voting rights as of November 30, 2025 under Article 223-16 of the AMF General Regulations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Company (NYSE:DBVT) reports the total number of shares and voting rights as of November 30, 2025 under Article 223-16 of the AMF General Regulations.
As of 11/30/2025 the total number of shares is 200,777,718. The total gross voting rights equals 200,777,718 and the total net voting rights is 200,667,869 (net total excludes shares without voting rights). ISIN: FR0010417345.
Details
News Market Reaction – DBVT
On Dec 3, the first trading day after this news, DBVT closed 0.70% above the previous close.
Data tracked by StockTitan Argus for the Dec 3 session.
Key Figures
- Total shares
- 200,777,718
- As of November 30, 2025
- Total gross voting rights
- 200,777,718
- As of November 30, 2025
- Total net voting rights
- 200,667,869
- Excludes shares without voting rights as of Nov 30, 2025
- Reference date
- 11/30/2025
- Effective date for share and voting-right count
Historical Context
-
Reported total shares and gross/net voting rights as of Nov 30, 2025.
-
Completed last patient visit in VITESSE Phase 3 VIASKIN Peanut trial.
-
Announced CEO fireside chat at Guggenheim healthcare innovation conference.
-
Appointed Kevin Trapp as Chief Commercial Officer for Viaskin Peanut strategy.
-
Disclosed total shares and voting rights as of October 31, 2025.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
isin financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Information Regarding the Total Number of Voting Rights and
Total Number of Shares of the Company as of November 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 11/30/2025 | 200,777,718 | Total gross of voting rights: 200,777,718 |
| Total net* of voting rights: 200,667,869 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.